Cancer Information Highlights, July 20, 2017

Cancer Information Highlights, July 20, 2017

Cancer Information Highlights

From the National Cancer Institute

Updating you about cancer causes, prevention, screening, treatment, coping, and more

New from NCI Improving Cancer Control in Rural Communities: Next Steps   Studies continue to show that people who live in rural parts of the United States do not receive the same kind of cancer care as those living in other areas. NCI’s Dr. Robert Croyle explains how the institute is working with multiple partners to better understand and address these differences. Large Study Confirms Risk of Cancer for Women with BRCA1 or BRCA2 Mutations   Results from this large study confirm that women with changes in the BRCA1 or BRCA2 genes are at higher risk for breast and ovarian cancer. New Rituximab Formulation Approved for Some Blood CancersThe Food and Drug Administration (FDA) has approved Rituxan Hycela, a drug to treat several types of lymphoma and leukemia that takes 5 to 7 minutes to inject. Rituximab, in comparison, can take several hours to give through an IV. PDQ Summary Updates Financial Toxicity (Financial Distress) and Cancer Treatment This new summary includes information for patients about the risk of having financial difficulty during cancer treatment, its effect on cancer patients, and ways to reduce financial distress. Cancer Pain We’ve updated our PDQ summary on cancer pain with new information about pain caused by radiation therapy for cancer.

Also of Interest

What Are Clinical Trials This section contains a wealth of information about clinical trials and why they are important to advancing cancer research.

Find NCI-Supported Clinical Trials Use our search form to look for clinical trials that are supported by NCI. If you aren’t sure where to start, this page also links to resources to help you.

BRCA1 and BRCA2: Cancer Risk and Genetic Testing This fact sheet explains the BRCA1 and BRCA2 genes, what to do if you test positive for changes in one of these genes, and potential risks and benefits of genetic testing.

Cancer Information Highlights, July 20, 2017